Cryo-Save Group N.V. : Cryo-Save Group N.V. - Storage results 2012

      Cryo-Save Group N.V. : Cryo-Save Group N.V. - Storage results 2012

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
leading international stem cell storage company and the largest family stem
cell bank in Europe, stored 35,100 new samples in 2012 (2011: 39,900 new


  *8,300 new samples stored in Q4 2012 (Q4 2011:10,300). Of these, 4,900 were
    new cord blood samples and 3,400 new cord tissue samples.
  *35,100 new samples stored in 2012 (2011:39,900). Of these, 21,200 were new
    cord blood samples and 13,900 new cord tissue samples.
  *239,000 samples have been stored in total at 31 December 2012.

Arnoud van Tulder, Chief Executive officer, commented:

"We are pleased to report a 35% storage growth in India compared to previous
year. This is an immediate result from measures we implemented in India. At
this point in time this considerable growth in one of ourvery promising
markets does not compensate the significant decline in Southern Europe,
predominantly Spain.

"We are convinced that 2013 will be a turn-around year to regain profitable
growth, as we continue to implement measures that focus on our current markets
and core services."

Please click here for full press release in PDF


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.